Showing results (31-40 of 52) with videos related to

Sort By:
Pageof 6
Diagnostics (Basel, Switzerland)|January 25, 2025
Clinical Utility of an Alzheimer's Disease Blood Test Among Cognitively Impaired Patients: Results from the Quality Improvement PrecivityAD2 (QUIP II) Clinician Survey StudyMark Monane, Demetrius M Maraganore, Robert M Carlile, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
BiomarkersSebastian Palmqvist, Noëlle Warmenhoven, Federica Anastasi, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 6, 2015
microRNA-33 Regulates ApoE Lipidation and Amyloid-β Metabolism in the BrainJaekwang Kim, Hyejin Yoon, Takahiro Horie, et al.
Molecular Neurodegeneration|May 2, 2021
A blood-based diagnostic test incorporating plasma Aβ42/40 ratio, ApoE proteotype, and age accurately identifies brain amyloid status: findings from a multi cohort validity analysisTim West, Kristopher M Kirmess, Matthew R Meyer, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 20, 2025
Accuracy of plasma biomarkers to detect Alzheimer's disease proteinopathy prior to dementiaKarly A Cody, Lianlian Du, Rachel L Studer, et al.
Annals of Clinical and Translational Neurology|March 28, 2023
Independent study demonstrates amyloid probability score accurately indicates amyloid pathologyIlana Fogelman, Tim West, Joel B Braunstein, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 17, 2024
Racial and ethnic differences in plasma biomarker eligibility for a preclinical Alzheimer's disease trialDoris Patricia Molina-Henry, Rema Raman, Andy Liu, et al.
Plos One|May 29, 2024
Protocol for a seamless phase 2A-phase 2B randomized double-blind placebo-controlled trial to evaluate the safety and efficacy of benfotiamine in patients with early Alzheimer's disease (BenfoTeam)Howard H Feldman, José A Luchsinger, Gabriel C Léger, et al.
Medrxiv : the Preprint Server for Health Sciences|May 18, 2026
Generating synthetic tau-PET scans in Alzheimer's disease from MRI, blood biomarkers and demographics with deep learningLinda Karlsson, Olof Strandberg, Ruben Smith, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 29, 2026
Evaluation of CSF and plasma tau species as fluid surrogate candidates for tau PET in prodromal to moderate Alzheimer's diseaseJulie Lee, Emily Olafson, Balazs Toth, et al.
Pageof 6